News
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...
6d
Pharmaceutical Technology on MSNMagazine: The GLP-1 shortage is over. What’s next for compounders?The astronomical rise in popularity of GLP-1RAs in recent years has led to a shortage, prompting users to turn to compounders ...
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for ...
The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...
11d
GlobalData on MSNFDA free to pursue semaglutide compounders after latest court rulingA US judge has rejected efforts by a compounded drugs industry group to keep making an alternative version of Novo Nordisk’s ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
Key takeaways Eli Lilly has filed lawsuits against four telehealth companies—Mochi Health, Fella Health, Willow Health, and ...
The decision came in response to a February lawsuit from a compounding industry group against the U.S. Food and Drug ...
The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results